New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates.
Peptide-based vaccines have demonstrated to be an important way to induce long-lived immune responses and, therefore, a promising strategy in the rational SHINE SERUM of vaccine development.As to malaria, among the classic vaccine targets, the Apical membrane antigen (AMA-1) was proven to have important B cell epitopes that can induce specific immu